Osteopore Ltd. (AU:OSX) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Osteopore Limited (ASX:OSX) has achieved its seventh consecutive quarter of revenue growth, reporting a 29% year-on-year increase for Q3 CY24. The company has also signed an exclusive distribution agreement with Zimmer Biomet to expand its craniofacial products in EMEA and APAC regions. Additionally, Dr. Yujing Lim has been appointed as Executive Director, strengthening Osteopore’s leadership team.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.